476040 — OrganoidSciences Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for OrganoidSciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	270	438	1,591	1,953	2,407
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	4,983	10,991	11,355	14,188	18,509
Operating Profit	-4,712	-10,553	-9,764	-12,235	-16,102
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-17,615	-24,111	-38,868	-11,536	-15,739
Provision for Income Taxes
Net Income After Taxes	-17,615	-24,111	-38,868	-11,536	-15,739
Minority Interest
Net Income Before Extraordinary Items
Net Income	-17,615	-24,111	-38,687	-11,246	-15,368
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-17,615	-24,111	-38,687	-11,246	-15,368
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-2,708	-3,706	-5,951	-1,729	-2,533
Dividends per Share